SCHEMBL12166010

SCHEMBL12166010

CC(C)(O)c1cnccc1-n1c2ccccc2c2cnccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.44
MAOB P27338 4/20 0.44
ACHE P22303 2/20 0.44
CYP2D6 P10635 1/20 0.42
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TOP2A P11388 1/20 0.35
CYP11B2 P19099 4/20 0.34
CYP11B1 P15538 2/20 0.34
SLC6A2 P23975 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1898156 0.92 MAOA (0.44) MAOAMAOBACHECYP2D6GRIN1
SCHEMBL12166027 0.88 P2RX4 (0.37) ALDH1A1CYP11B2CYP11B1KDM4E
SCHEMBL1894782 0.85 TSPO (0.38) MAOAMAOBACHEALDH1A1CYP11B2
SCHEMBL12166087 0.77 ACHE (0.35) MAOAMAOBACHECYP2D6GRIN1
SCHEMBL11926705 0.77 ALDH1A1 (0.47) ALDH1A1CYP11B2CYP11B1POLBKDM4E
SCHEMBL12166118 0.75 TSPO (0.38) MAOAMAOBACHEALDH1A1CYP11B2
SCHEMBL20277277 0.74 MAOA (0.53) MAOAMAOBACHECYP2D6GRIN1
SCHEMBL2556933 0.74 ALDH1A1 (0.43) ALDH1A1CYP11B2CYP11B1POLBKDM4E
SCHEMBL21420952 0.72 MAOA (0.54) MAOAMAOBACHECYP2D6GRIN1
SCHEMBL12166007 0.72 NR4A2 (0.45) MAOAMAOBACHEHDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012599-B2 Nitrogen-containing condensed heterocyclic compounds for OLEDs MERCK PATENT GMBH (DE) 2015-04-21 US disclosed
US-9012599-B2 Nitrogen-containing condensed heterocyclic compounds for OLEDs MERCK PATENT GMBH (DE) 2015-04-21 US disclosed
US-20120232241-A1 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) 2012-09-13 US disclosed
US-20120232241-A1 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) 2012-09-13 US disclosed
WO-2011060867-A1 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS MERCK PATENT GMBH (DE) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232241-A1 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS OCIAD2, OCIAD1, ODC1 MAOA 327/4885MAOB 147/4885ACHE 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.